Cryosite Limited (ASX:CTE) is an Australian company specialising in temperature-controlled storage and logistics solutions for the life sciences and pharmaceutical industries, in particular for clinical trials and biological materials. It’s positioned to capitalise on the explosive growth in cell and gene therapies (CGT), mRNA-based medicines, and biological sample management. Founded in 2000 as Australia’s first private cord blood bank, the company has evolved into a specialised end-to-end provider of outsourced storage and logistics services, with a focus on compliance, safety and efficiency. It is the market leader in Australia, and strong cash flows and a debt-free balance sheet have allowed the company to grow revenues organically to date. CTE’s world-class facilities and strong regulatory position may well make it an acquisition target for global players seeking entry into the Asia-Pacific market.
